jain.com

Greenshoe option for additional convertible notes

Company: Marathon Digital

This claim was marked delayed on September 4, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2024-12-03
Promised by
2024-12-16
Promised amount
150.0 USD
Current status
delayed

The claim, verbatim

Initial Purchasers granted option to purchase up to additional $150 million aggregate principal amount of notes within 13-day period from issuance

Source (primary)

Marathon Digital 8-K filed 2024-12-04 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “The Company also granted the Initial Purchasers an option to purchase up to an additional $150 million aggregate principal amount of the notes within a 13-day period beginning on, and including, the date on which the notes were first issued.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Marathon Digital 8-K filed 2024-12-04

Quote: “The Company also granted the Initial Purchasers an option to purchase up to an additional $150 million aggregate principal amount of the notes within a 13-day period beginning on, and including, the date on which the notes were first issued.”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 4, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.